116 related articles for article (PubMed ID: 24966143)
21. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group.
Ehrenforth S; Junker R; Koch HG; Kreuz W; Münchow N; Scharrer I; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S97-104. PubMed ID: 10650845
[TBL] [Abstract][Full Text] [Related]
22. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
Okumus G; Kiyan E; Arseven O; Tabak L; Diz-Kucukkaya R; Unlucerci Y; Abaci N; Unaltuna NE; Issever H
Clin Appl Thromb Hemost; 2008 Apr; 14(2):168-73. PubMed ID: 17895505
[TBL] [Abstract][Full Text] [Related]
23. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism in neonates and children.
Kenet G; Nowak-Göttl U
Best Pract Res Clin Haematol; 2012 Sep; 25(3):333-44. PubMed ID: 22959549
[TBL] [Abstract][Full Text] [Related]
25. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
26. Thrombophilia as a multigenic disease.
Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of factor V Leiden and prothrombin G20210A gene mutation.
Al-Aama JY
Saudi Med J; 2005 Nov; 26(11):1844. PubMed ID: 16311688
[No Abstract] [Full Text] [Related]
28. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
[TBL] [Abstract][Full Text] [Related]
29. Venous thromboembolism in young female while on oral contraceptives: high frequency of inherited thrombophilia and analysis of thrombotic events in 400 czech women.
Dulícek P; Malý J; Pecka M; Beránek M; Cermáková E; Malý R
Clin Appl Thromb Hemost; 2009 Oct; 15(5):567-73. PubMed ID: 19117968
[TBL] [Abstract][Full Text] [Related]
30. Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism.
Couturaud F; Leroyer C; Julian JA; Kahn SR; Ginsberg JS; Wells PS; Douketis JD; Mottier D; Kearon C
Chest; 2009 Dec; 136(6):1537-1545. PubMed ID: 19592474
[TBL] [Abstract][Full Text] [Related]
31. Hereditary thrombophilia in an unselected cohort of venous thrombosis patients in Singapore.
Lee LH; Liu TC; Kuperan P; Tan LK; Tan D; Poon ML; Ong KH; Fong SZ; Tan MY; Ng HJ
J Clin Pathol; 2011 Sep; 64(9):814-7. PubMed ID: 21593345
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
[TBL] [Abstract][Full Text] [Related]
33. Inherited risk factors in low-risk venous thromboembolism in patients under 45 years.
Yilmaz S; Gunaydin S
Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):21-3. PubMed ID: 25326427
[TBL] [Abstract][Full Text] [Related]
34. Thrombophilia testing in patients with venous thrombosis.
Caprini JA; Goldshteyn S; Glase CJ; Hathaway K
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):550-5. PubMed ID: 16055356
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Hereditary Thrombophilia in Patients Older Than 75 Years With Venous Thromboembolism Referred for Thrombophilia Screening.
Siguret V; Emmerich J; Belleville T; Golmard JL; Mazoyer E; Gouin-Thibault I; Pautas E
J Gerontol A Biol Sci Med Sci; 2015 Aug; 70(8):977-81. PubMed ID: 25665832
[TBL] [Abstract][Full Text] [Related]
36. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
[TBL] [Abstract][Full Text] [Related]
37. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of thrombophilic traits in children with family history of thromboembolism.
Calhoon MJ; Ross CN; Pounder E; Cassidy D; Manco-Johnson MJ; Goldenberg NA
J Pediatr; 2010 Sep; 157(3):485-9. PubMed ID: 20546786
[TBL] [Abstract][Full Text] [Related]
39. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
[TBL] [Abstract][Full Text] [Related]
40. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
